Tom Sundlof joined Blank Rome as a partner in the life sciences industry team and corporate, M&A, and securities practice group in Washington, DC, the firm announced Wednesday.
Sundlof’s practice focuses on regulatory, compliance, and enforcement matters for medical devices, combination products, and other FDA-regulated products. He will help domestic and international clients navigate FDA regulations from designing clinical trials to maintaining post-market compliance, the firm said.
He joins from the FDA’s Office of the Chief Counsel.
This story was produced by Bloomberg Law Automation.
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.